October 2026

42 Articles

Beyond the Guidelines

Sex and gender in the era of personalized medicine: beyond one-size-fits-all

23 July 2026
Author(s): Maria Rosa Ballester-Verneda

Medicine has traditionally relied on standardized diagnostic and therapeutic protocols perceived as universal and neutral. However, this presumed neutrality reflects a structural bias in the... more

Clinical Insights

Carbapenem-resistant Acinetobacter baumannii pneumonia: Treatment challenges

19 August 2026
Author(s): Demosthenes Makris, Jordi Rello

Carbapenem-resistant Acinetobacter baumannii (A. baumannii) (CRAB) is a cause of ventilator-associated pneumonia (VAP) that can be devastating. Suggested approaches are based on literature review,... more

Commentary

Breaking LDL-cholesterol inertia after myocardial infarction: from discharge prescription to closed-loop care

20 August 2026
Author(s): Pierre-Guillaume Piriou, Philippe Gabriel Steg

Acute myocardial infarction is both an emergency and the beginning of a prolonged period of exceptionally high recurrent cardiovascular risk. Few components of secondary prevention are supported by... more

A step toward precision screening for occult cancer after venous thromboembolism

19 August 2026
Author(s): M Di Nisio, N van Es

Venous thromboembolism (VTE) has long been recognized as one of the earliest clinical manifestations of an underlying malignancy. More than 160 years after Trousseau first recognized the association... more

Subclinical atrial fibrillation in patients treated with Bruton’s tyrosine kinase inhibitors: ‘Much ado about nothing or phantom menace’

18 August 2026
Author(s): Andrés J. Muñoz Martín, Eduardo Zatarain-Nicolás, Sara Pérez Ramírez

Bruton's tyrosine kinase inhibitors (BTKis) have reshaped the therapeutic landscape of B cell malignancies, significantly improving survival outcomes [1]. However, cardiovascular side effects,... more

Hyperuricemia and prevention of cardiometabolic disease: Unexplored is not unexpected

1 August 2026
Author(s): Claudio Borghi, Bentivenga Crescenzio

For decades, the management of hyperuricemia has been largely driven by the occurrence of gout. Outside the context of crystal-induced disease, asymptomatic hyperuricemia has traditionally been... more

Ideas and Opinions

Why rare uninformative findings appear highly specific

6 July 2026
Author(s): José Nunes de Alencar

Sensitivity and specificity remain the dominant metrics for evaluating diagnostic tests in clinical epidemiology, and the Spin and Snout mnemonic—“specific findings rule disease in, sensitive... more

Internal Medicine Flashcard

A Woman with Progressive Skin Ulceration

20 July 2026
Author(s): Kodai Sakiyama, Hiroyuki Yano, Mitsuyo Kinjo

A 62-year-old woman with heavy alcohol use developed difficulty walking and reduced oral intake over two weeks, followed by altered consciousness, disorientation, hallucinations, and watery diarrhea... more

Chronic hyperkeratotic and pustular cutaneous lesions of the hand

23 June 2026
Author(s): Claude Bachmeyer, Philippe Moguelet, Jean-Benoit Monfort

A 49-year-old Algerian woman, was referred for evaluation of cutaneous lesions evolving for four years suggestive of chronic infection. His medical history was relevant for diabetes mellitus... more

Letter to the Editor

Reconsidering the interpretation of prescribing shifts and treatment response in the AMBI-RA study. Authors’ reply

24 August 2026
Author(s): Riccardo Bertola, Carlo Garaffoni, Beatrice Maranini, Alessandra Bortoluzzi, Ettore Silvagni

We read with great interest the letter by Huang M. et al. [1] on the AMBI-RA study by our group [2], and we are grateful for their comments which permit to better elucidate the significance of our... more

First UK report of Imlifidase-enabled deceased donor kidney transplantation in highly sensitised recipients

12 August 2026
Author(s): Asha Mohan, Clare Collins, David Briggs, Nithya Krishnan, Atul Bagul

Dear Editor

Reflections on left atrial enlargement. Authors’ reply

7 August 2026
Author(s): Bianca Clerici, Gian Marco Podda

Dear Editor,

Does T90 reflect OSA-specific hypoxic burden or underlying pulmonary disease? Author's reply

13 July 2026
Author(s): Francesco Bertoldo, Giulia Sartori, Matteo Lombini, Alberto Fantin, Ernesto Crisafulli

Dear Editor,

Twelve-year trends in sex and age of patients with COPD and chronic respiratory failure undergoing pulmonary rehabilitation

26 June 2026
Author(s): Matteo Vigna, Gaia Riboni, Valentina Tibollo, Riccardo Bellazzi, Michele Vitacca

Dear Editor,

Reconsidering the interpretation of prescribing shifts and treatment response in the AMBI-RA study

14 May 2026
Author(s): Mai Huang, Zhicheng Huang, Xin Gan

We read with great interest the AMBI-RA study by Bertola et al. [1], which examined changes in b/tsDMARD prescribing and short-term treatment outcomes after regulatory restrictions on Janus kinase... more

Paroxysmal atrial fibrillation and bleeding: Pattern, prescription, or both? A call for aspirin-informed analyses in COMBINE-AF

9 May 2026
Author(s): Michal Pruc, Karol Momot, Bartosz Maj, Lukasz Szarpak

Ntaios and colleagues report an exceptional individual patient-level analysis from COMBINE-AF (n = 71,466), providing unusually precise estimates of outcome gradients between paroxysmal atrial... more

Rethinking renal protection in patients with heart failure and reduced ejection fraction

2 May 2026
Author(s): Wei Chen, Kexin Ye

We read with great interest the review titled “Renal protection in heart failure with reduced ejection fraction: not all that glitters is gold” by Elisa Russo and colleagues, published in your... more

Dialysis, but not severe renal dysfunction, is associated with excess bleeding in venous thromboembolism: Insights from a nationwide registry

2 May 2026
Author(s): Takahiro Kuno, Norimichi Koitabashi, Yugo Yamashita, Takeshi Morimoto, Hideki Ishii, on behalf of the COMMAND VTE Registry-2 Investigators

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common and potentially fatal complication in patients with chronic kidney disease (CKD), including... more

Refining cerebrovascular risk in left atrial enlargement: integrating CKM framework and atrial cardiomyopathy phenotyping

24 April 2026
Author(s): Weikai Dong, Guangmin Yang, Qiang Wang

We read with great interest the article “Left atrial enlargement and 1-year cerebrovascular events in subjects without atrial fibrillation: A prospective cohort study” by Clerici et al. [1]. The... more

Beyond survival: nuances in the robustness of SGLT2 inhibitor evidence for HFpEF

20 April 2026
Author(s): Qi Sun, Longqing Yu

We read with great interest the article by Zuin et al., which provides a rigorous evaluation of the robustness of randomized controlled trial (RCT) evidence for sodium-glucose co-transporter 2... more

From structure to function: A commentary on left atrial enlargement and cerebrovascular events and the potential value of left atrial strain

28 March 2026
Author(s): Man Luo, YiHuai Tian, Xun Ou

I read with great interest the article by Clerici and colleagues titled "Left atrial enlargement and 1-year cerebrovascular events in subjects without atrial fibrillation: A prospective cohort study... more

Original Article

Long-term mortality in patients admitted acutely for chronic liver disease in England: A national cohort study

24 August 2026
Author(s): Cori Campbell, Benjamin Palafox, Vikram Bains, James Doidge, Jan van der Meulen, Kate Walker, William Bernal

Mortality of CLD patients after a FEA in England is exceptionally high, with marked differences according to sociodemographic characteristics, aetiology, disease severity, and geographic region.... more

Unlocking the benefits of allopurinol: the role of timely initiation and adherence in cardiovascular and renal outcomes in hyperuricemia

20 June 2026
Author(s): András Inotai, Dávid Nagy, Gábor Kovács, Sándor Kovács, Tamás Dóczi, Balázs Nagy, Valerie Tikhonoff, Luca Degli Esposti, Zoltán Kaló, Claudio Borghi

Hyperuricemia (HU) is a prevalent chronic metabolic condition characterized by elevated serum uric acid (SUA) levels [1]. The accumulation of monosodium urate crystals in joint and extra-articular... more

Diagnostic and therapeutic inertia for LDL cholesterol management of consecutively verified patients with acute myocardial infarction

19 June 2026
Author(s): Felice Gragnano, Chiara Artana, Greta Carrara, Alice Sacco, Claudio Montalto, Marco Mennuni, Marco Zuin, Fabrizio D’Ascenzo, Fabrizio Del Nevo, Vincenzo De Sio, Leonardo De Luca, Giulia Spoto, Giuseppe Musumeci, Fabrizio Oliva, Gaetano Maria De Ferrari, Daniele Grosseto, Paolo Calabrò, Giuseppe Patti, Gianluca Campo, Sergio Leonardi, on behalf of the ATBV Quality Matters Investigators

The effective management of low-density lipoprotein cholesterol (LDL-C) after acute myocardial infarction (AMI) is a cornerstone of secondary prevention in contemporary cardiovascular care [1–5].... more

Asymptomatic atrial fibrillation in patients treated with BTK inhibitors in hematologic malignancies: a systematic review and metanalysis

16 June 2026
Author(s): Giuseppe Boriani, Jacopo Francesco Imberti, Annachiara Valenti, Marco Vitolo, Teresa Lopez-Fernandez, Davide Antonio Mei

Atrial fibrillation (AF) is a frequent complication of Bruton’s tyrosine kinase inhibitor (BTKi) therapy, yet the proportion of asymptomatic AF events in this setting remains poorly defined.

Development and external validation of an international score to predict cancer 1 year after venous thromboembolism

25 May 2026
Author(s): Luis Jara-Palomares, Behnood Bikdeli, David Jiménez, Alfonso Muriel, Yugo Yamashita, Marc Carrier, Isabelle Mahé, Farès Moustafa, José Luis Fernández-Reyes, Juan Gorostidi-Pérez, María de la Roca Toda, Peter Verhamme, Maria Barca-Hernando, Melisa González-Acosta, Henry Antonio Andrade-Ruiz, Manuel Monreal, the RIETE Investigators

Routine cancer screening is not recommended after venous thromboembolism (VTE), but improved risk stratification may support tailored strategies.

Epicardial fat enhances prediction of exercise-induced hypertension and ventricular arrhythmias in asymptomatic normotensive individuals

23 May 2026
Author(s): Klara Komici, Giuseppe Rengo, Grazia Daniela Femminella, Raffaela Pagliaro, Maria Luisa D'Onghia, Laura Fasciano, Gaetano Santulli, Pasquale Mone, Andrea Bianco, Germano Guerra

Exercise stress testing is commonly used to evaluate the cardiovascular response to exercise and to identify coronary artery abnormalities and arrhythmias. The normal physiological response to... more

Discharge medical treatment implementation and predictors of a successful decongestion in patients with acute heart failure: first data from the BRING-UP 3 Heart Failure Study

8 May 2026
Author(s): BRING-UP 3 Heart Failure Investigators

Current discharge management of acute heart failure patients and clinical predictors of successful decongestion in a large Italian network of cardiology sites.AF, atrial fibrillation; BMI, body mass... more

Infectious complications of ANCA-associated vasculitis: Description and associated outcome

8 May 2026
Author(s): Jeanne Morin, Pierre-André Jarrot, Justine Solignac, Flora Lefevre, Philippe Brunet, Gilles Kaplanski, Stéphane Burtey, Laurent Daniel, Julia Torrents, Julien Faraut, Noémie Jourde-Chiche, Mickaël Bobot

ANCA-associated vasculitis (AAV) are a systemic autoimmune disease that primarily affect small vessels, according to the Chapel Hill classification [1] and cause necrotizing vasculitis and result... more

Hypertension and blood pressure profiles in patients with acute intermittent porphyria: a prospective case-control study

7 May 2026
Author(s): Krzysztof Jaworski, Robert Wasilewski, Jerzy Windyga, Ilona Kowalik, Hanna Szwed, Agnieszka Lipniacka, Magdalena Niedolistek, Joanna Was, Andrzej Januszewicz, Reinhold Kreutz, Franz Messerli, Rafal Dabrowski

Acute intermittent porphyria (AIP), a rare disorder of heme biosynthesis, may manifest with neurovisceral crises affecting autonomic regulation. This study aimed to assess blood pressure (BP) pattern... more

Practice Guidelines

Identification and management of sarcopenia in patients with multimorbidity: An EFIM critically appraised and adapted guideline

13 August 2026
Author(s): M. Bernabeu-Wittel, I. Marín-León, C. Angermann, P. Cubo-Romano, Z. Cvetković, A. Dima, M. Fissah, J.A. García-García, S. García-Rubio, E. Kravvariti, A. Kurrle, O. Lidove, Z. Lys, O. Para, L. Santos, A. Tuttolomondo, J. Václavík, J. Voicehovska, D. Nieto-Martín

Sarcopenia is highly prevalent among adults with multimorbidity and contributes substantially to frailty, disability, prolonged hospitalization, and mortality. International guidelines offer robust... more

Review Article

Testosterone therapy in chronic kidney disease patients: an underutilized resource

29 June 2026
Author(s): Sandro La Vignera, Rosita A. Condorelli

Testosterone deficiency is highly prevalent in men with chronic kidney disease (CKD), affecting 30–70% of patients depending on disease stage and diagnostic criteria. Despite its frequency and... more

Retinal microcirculation as a window to coronary artery disease

17 June 2026
Author(s): Weronika Kowalczyk, Mikołaj Basza, Joanna Przybek-Skrzypecka, Łukasz Kołtowski, Jacek Szaflik, Justyna Izdebska

Coronary artery disease includes obstructive epicardial stenosis and ischemia with non-obstructive coronary arteries driven by microvascular dysfunction. Population screening is limited by the... more

Healthcare sustainability and the planetary crisis: A solution orientation

13 June 2026
Author(s): Elizabeth Cerceo

The climate crisis is an escalating public health emergency that demands urgent, systemic action from the healthcare sector. This article presents a solution-oriented framework for integrating... more

Linking the exposome to frailty: pathways, mechanisms, clinical implications, and prevention

11 June 2026
Author(s): Mustafa Guldan, Ermeena Shah, Rama Al-Shiab, Lasin Ozbek, Adrian Covic, Mehmet Kanbay

Frailty is a state of heightened vulnerability arising from multisystem decline, in which minor stressors can precipitate disproportionate deterioration in function and health. It predicts falls,... more

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness